About Thomas Mathers
Thomas Mathers is an executive chairman and interim CEO at Aer Therapeutics.
Experience
This experience comes from Thomas Mathers's profile and from SEC filings. For roles taken from filings, the years are when the filings name Thomas Mathers in the role, so the role may have started earlier or lasted longer.
AA
ANAVEON AG Current
Chairman of the Board
2026 – Present
CT
Certa Therapeutics Current
Vice Chairman
2025 – Present
Aer Therapeutics, Inc. Current
Executive Chairman and Interim CEO
Executive Chairman of the Board of Directors (2023 – Present)
2023 – Present · Research Triangle Park, NC
Develops inhaled medicines for people with lung diseases involving mucus blockages.
PC
Pappas Capital Current
Partner
2018 – Present
BO
Biotechnology Innovation Organization Current
Board Member, Treasurer, Executive Committee Member
2006 – Present
UA
U.S. Department of Veterans Affairs
Member, Research Advisory Committee on Gulf War Veterans' Illnesses
2023 – 2026
AC
Allievex Corporation
Founder, President & CEO
2019 – 2024
CC
CoLucid Pharmaceuticals, Inc (NASDAQ: CLCD)
President & CEO
2011 – 2017
PI
Peptimmune, Inc.
President & CEO
2003 – 2011
CD
Cell Based Delivery
President & CEO
2002 – 2003
CP
Cardion Pharmaceuticals
VP and General Manager
2001 – 2002
GE
Genzyme
VP-Strategic Development
1993 – 2001
UA
US Army
AH-64 Apache Helicopter Pilot and Platoon Leader
1988 – 1992
Key Colleagues at Startups
The people Thomas Mathers works with at each company, as listed on that company's latest Form D.
Aer Therapeutics, Inc. · Form D, Aug 19, 2026
Evan Caplan
Partner, OrbiMed and director
Tim Shannon
Partner, Canaan Partners and director
John Fahy
Founder and Chief Clinical Consultant, director
Christy Shaffer
Partner, Hatteras Ventures and director